A review of malignant meningiomas: diagnosis, characteristics, and treatment
- 21 August 2010
- journal article
- review article
- Published by Springer Science and Business Media LLC in Journal of Neuro-Oncology
- Vol. 99 (3), 433-443
- https://doi.org/10.1007/s11060-010-0348-9
Abstract
Anaplastic or malignant meningiomas (WHO Grade III) represent the most rare but aggressive subtype, accounting for 1–3% of all intracranial meningiomas. Due in large part to their scarcity, malignant meningiomas have been understudied and therefore represent an area where significant clinical advances may be made. To this point, our understanding of the genetic and histologic attributes of these lesions has grown, though the management and treatment of these aggressive tumors is less well elucidated and thus has room for further study. In this review, we describe the current understanding of malignant meningiomas in terms of their genetic alterations and unique histologic markers. Using this as a foundation, we will then discuss the current therapeutic strategies for managing these lesions and the future direction that such interventions may take.This publication has 40 references indexed in Scilit:
- Outcome and survival following primary and repeat surgery for World Health Organization Grade III meningiomasJournal of Neurosurgery, 2010
- Atypical and Malignant Meningioma: Outcome and Prognostic Factors in 119 Irradiated Patients. A Multicenter, Retrospective Study of the Rare Cancer NetworkInternational Journal of Radiation Oncology*Biology*Physics, 2008
- Review of meningioma histopathologyNeurosurgical Focus, 2007
- Targeted drug therapy for meningiomasNeurosurgical Focus, 2007
- The 2007 WHO Classification of Tumours of the Central Nervous SystemActa Neuropathologica, 2007
- Progesterone-receptor index in meningiomas: correlation with clinico-pathological parameters and review of the literatureNeurosurgical Review, 2004
- A Role for Chromosome 9p21 Deletions in the Malignant Progression of Meningiomas and the Prognosis of Anaplastic MeningiomasBrain Pathology, 2002
- Alterations of the Tumor Suppressor Genes CDKN2A (p16INK4a), p14ARF, CDKN2B (p15INK4b), and CDKN2C (p18INK4c) in Atypical and Anaplastic MeningiomasThe American Journal of Pathology, 2001
- ?Malignancy? in meningiomasCancer, 1999
- Atypical and anaplastic meningiomas: Radiology, surgery, radiotherapy, and outcomeSurgical Neurology, 1986